Chemotherapy Biotherapy Certification ONS Practice Testq

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the ONS Chemotherapy Biotherapy Certification Exam. Leverage flashcards and multiple choice questions, complete with hints and explanations. Equip yourself for exam success!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


How are chemotherapy drugs classified?

  1. By their chemical structure only

  2. According to their cytotoxic effect location

  3. Based on patient demographics

  4. By their manufacturing process

The correct answer is: According to their cytotoxic effect location

Chemotherapy drugs are classified primarily according to their cytotoxic effect location because this categorization reflects how these drugs interact with cancer cells during different phases of the cell cycle. Understanding which type of chemotherapy drug is effective at targeting specific processes in cancer cell division helps clinicians select appropriate treatments for various types of malignancies. For instance, some chemotherapy agents are classified as cell-cycle phase-specific or cell-cycle phase-nonspecific. Cell-cycle phase-specific drugs, such as antimetabolites, target cells at specific points of the cycle, while cell-cycle phase-nonspecific drugs can act on cells regardless of their cycle phase, impacting a broader range of cells. This classification is crucial for determining the most effective therapeutic strategies based on the specific characteristics of a patient's cancer. Other classification methods, such as by chemical structure, might provide insights into the characteristics and potential side effects of the drugs, but they do not directly inform treatment strategies in the same way that understanding their cytotoxic effects does. Similarly, manufacturing processes and patient demographics, while important in the overall context of drug development and treatment considerations, are not primary methods for classifying chemotherapy agents in the clinical setting.